GoodRx Holdings Inc - 2025年季度报告

FORM10-Q GoodRx Holdings, Inc. Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).YesxNoo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reportingcompany,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Table of Contents FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statementsto be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Allstatements other than statements of historical facts contained in this Quarterly Report on Form 10-Q may be forward-lookingstatements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” this Quarterly Report on Form 10-Q include, but are not limited to statements regardingourfuture results of operations andfinancial position, industry and business trends, the anticipated impact of ongoing changes in the U.S. retail pharmacylandscape and macroeconomic environment, the impact of store closures and the announced bankruptcy of one of our retailpartners on our business, our value proposition, our collaborations and partnerships with third parties, stock compensation, The forward-lookingstatements in this Quarterly Report on Form 10-Q are only predictions. We have based theseforward-looking statements largely on our current expectations and projections about future events and financial trends thatwe believe may affect our business, financial condition and results of operations. Forward-looking statements involve knownandunknown risks,uncertainties and other important factors that may cause our actual results,performance orachievements to be materially different from any future results, performance or achievements expressed or implied by theforward-looking statements, including, but not limited to, risks related to our limited operating history and early stage ofgrowth; our recent growth rates may not be sustainable or indicative of future growth; our ability to achieve broad marketeducation and change consumer purchasing habits; our general ability to continue to attract, acquire and retain consumersin a cost-effective manner; our significant reliance on our prescription transactions offering and ability to expand ourofferings; changes in medication pricing and the significant impact of pricing structures negotiated by industry participants;our general inability to control the categories and types of prescriptions for which we can offer savings or discounted prices;our reliance on a limited number of industry participants, including pharmacy benefit managers, pharmacies, and pharmamanufacturers; the competitive nature of industry; risks related to pandemics, epidemics or outbreak of infectious disease;the accuracy of our estimate of our addressable market and other operational metrics; our ability to respond to changes inthe market for prescription pricing and to maintain and expand the use of GoodRx codes; our ability to maintain positiveperception of our platform or maintain and enhance our brand; risks related to any failure to maintain effective internalcontrol over financial reporting; risks related to use of social media, emails, text messages and other messaging channels aspart of our marketing strategy; our dependence on our information technology systems and those of our third-party vendors,and risks related to any failure or significant disruptions thereof; risks related to government regulation of the internet, e-commerce, consumer data and privacy, information technology and cybersecurity;risks related to the use of AI and machinelearning in our business;risks related to a decrease in consumer willingness to receive correspondence or any technical,legal or any other restrictions to send such correspondence; risks related to any failure to comply with applicable data Table of Contents forward-looking statements contained in this Quarterly Report on Form 10-Q, whether as a result of any new information,future events or otherwise. We periodically post information that may be important to investors on our investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and forcomplyingwith our disclosure obligations under Regulation FD.Accordingly,investors and potential investors areencouraged